Trading IdeasFundamentals

Eiko Lifesciences Limited

BSE: EIKO · Specialty Chemicals · sector

₹50.31BSE close 2026-10-26

Key numbers

Market cap₹72 cr
Price₹50.31
52w high / low₹64 / ₹43
P/E14.4xSector median 22.6x
P/B1.1xSector median 2.6x
Book value₹47.9
Dividend yield–Sector median 0.60%
ROE7.8%Sector median 10.6%
ROCE10.8%Sector median 12.9%
OPM13.4%Sector median 12.1%
Debt / equity0.07xSector median 0.18x
EV/EBITDA8.1xSector median 15.1x
Interest cover19.4x
Current ratio3.08x
Sales growth 3y+42.2%Sector median +5.0%
Profit growth 3y+80.1%Sector median +0.9%
PEG0.28x

Last 12 months to Jun 2026, Consolidated. "Sector median" = middle value of 107 companies in Specialty Chemicals (P/E median leaves out loss-making companies). Tap ? for what a number means.

Things to know

Plain facts from the filings, built by the same fixed rules for every company. A line appears only when the data for it is available. Not a view on the stock.

Charts

Weekly close · high ₹69.59 · low ₹43.87
Sep 2024Apr 2025Oct 2025Apr 2026

Quarterly results

₹ crMar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue111112121817
EBITDA222222
OPM %14.6%14.1%15.1%15.7%12.5%11.6%
Other income000000
Net profit111111
EPS (₹)0.800.660.780.880.930.91
Revenue YoY+62.7%+56.4%
Profit YoY+23.8%+44.0%

Consolidated figures where filed. Latest quarter Jun 2026.

Profit & loss (yearly)

₹ crFY22FY23FY24FY25FY26TTM
Revenue251828385359
EBITDA112378
Net profit111245
EPS (₹)0.900.920.731.623.263.50
Revenue growth-27.9%+52.5%+34.8%+40.0%–
Profit growth+8.5%-2.6%+181.3%+113.3%–
Dividend / share (₹)–––––
Compounded growth3 years5 yearsLast 12 months
Sales+42.2%––
Net profit+80.1%––
EPS+52.5%––
Share price–-9.2% (2y)-5.4%

Balance sheet

₹ crFY25FY26
Shareholders' equity5769
Borrowings35
Cash & equivalents1214
Total assets6689
Fixed assets2322
Capital work in progress00
Investments715
Receivables1120
Inventory64
Payables313

Year-end figures from the March annual filing.

Cash flow

₹ crFY25FY26
Cash from operations32
Cash from investing-11-9
Cash from financing78
Capex100
Free cash flow-72

Free cash flow = cash from operations − capex.

Ratios by year

₹ crFY25FY26
ROE %3.7%6.5%
ROCE %5.2%10.1%
Debtor days105140
Inventory days6535
Payable days37111
Cash conversion cycle (days)13364
Working capital days258222

Peers in Specialty Chemicals

CompanyMarket capP/EP/BROEROCEOPMSales 3yDiv yield
PIDILITIND₹1,50,431 cr56.8x13.9x25.7%33.4%24.5%+7.4%1.01%
FLUOROCHEM₹46,168 cr75.4x5.9x8.1%10.0%25.6%-4.2%0.07%
NAVINFLUOR₹39,306 cr49.7x9.9x23.9%22.2%33.7%+16.8%0.18%
DEEPAKNTR₹19,676 cr25.1x3.4x14.0%15.3%15.4%-0.4%0.52%
AETHER₹19,529 cr82.8x8.0x10.1%11.4%30.9%+21.2%–
ATUL₹15,762 cr19.8x2.5x11.9%16.9%17.9%+7.9%0.47%
AARTIIND₹15,539 cr29.3x2.6x9.2%8.0%14.9%+7.8%0.24%
FINEORG₹15,328 cr35.0x5.8x17.7%21.3%21.7%-7.8%0.22%
BASF₹13,174 cr20.5x3.3x16.9%22.0%5.9%+3.1%0.66%
EIKO₹72 cr14.4x1.1x7.8%10.8%13.4%+42.2%–

All 107 companies in Specialty Chemicals →

Business segments (2026-06-30)

SegmentRevenueShareEBITMargin
Specialty & Fine Chemicals₹15 cr91.1%₹1 cr6.5%
Logistics₹2 cr8.9%₹0 cr19.2%

Dividends & corporate actions

Ex-dateActionDetail
2017-09-20DividendDividend Rs 0.25

Documents

Links go to the original files on the exchange website.

About the company

SectorCommodities
IndustrySpecialty Chemicals
Sub-industrySpecialty Chemicals
SymbolEIKO
BSE code540204
ISININE666Q01016
Face value₹10.0
Incorporated–
Website–
Plants (India / abroad)–

Data built 2026-10-23 from BSE company filings (inline XBRL: Integrated Filing - Finance) + BSE results summary for earlier years; price = BSE close 2026-10-26.